XJPX
3401
Market cap2.00bUSD
Jul 10, Last price
1,662.50JPY
1D
-1.13%
1Q
-2.98%
Jan 2017
-29.82%
Name
Teijin Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Teijin Limited, a global enterprise established in Tokyo, Japan, in 1918, operates across multiple key sectors including fibers, films, composites, healthcare, and IT. The company's advanced materials portfolio encompasses various fibers such as aramid, carbon, and polyester, alongside specialized films like polycarbonate and high-density polyethylene. It also produces resins, molded parts, and additives, as well as lightweight glass and carbon fiber reinforced composites, particularly for automotive applications. In the healthcare domain, Teijin develops pharmaceuticals addressing a range of conditions, including bone and joint, respiratory, and cardiovascular diseases. It further provides medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders, complemented by orthopedic implants and functional food ingredients. Beyond materials and healthcare, Teijin offers IT solutions like Recopic, an RFID technology for inventory management. The company also leverages its engineering expertise to address global issues such as environmental pollution, energy supply stability, and challenges associated with an aging workforce population.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||